Samlyn Capital, LLC

SEC CIK: 0001421097
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Samlyn Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overview All 13F holders of DYN Full Q2 2026 holdings

Shares (Q2 2026): 1,754,708
Value: $39.0M
% of portfolio: 0.6%
Quarters held: 3; Since Q4 2025

Holdings of DYN by Samlyn Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,754,708	$39.0M	0.6%	−167,835−8.7%	Reduced	Holders
Q1 2026	1,922,543	$34.9M	0.6%	+429,468+28.8%	Added	Holders
Q4 2025	1,493,075	$29.2M	0.5%	+1,493,075	New	Holders